Study identifies a powerful strategy to overcome drug resistance in breast cancer

[News]

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications, identifies a powerful strategy to overcome drug resistance in breast cancer by simultaneously targeting two key cell-cycle regulators, CDK2 and CDK4/6.

More... (https://www.news-medical.net/news/20260122/Study-identifies-a-powerful-strategy-to-overcome-drug-resistance-in-breast-cancer.aspx)